Long non-coding RNA LINC01116 accelerates the progression of keloid formation by regulating miR-203/SMAD5 axis

Burns. 2021 May;47(3):665-675. doi: 10.1016/j.burns.2020.07.027. Epub 2020 Aug 11.

Abstract

Background: Emerging evidence reveals the importance of long non-coding RNAs (lncRNAs) in the development and progression of keloid formation. However, the roles and molecular mechanism of lncRNA LINC01116 in the progression of keloid formation remain largely unknown.

Methods: The expression levels of LINC01116, microRNA-203 (miR-203) and SMAD family member 5 (SMAD5) were measured by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot. Cell proliferation, migration and invasion were detected by Cell counting Kit-8 (CCK-8) assay and transwell assay. Flow cytometry and western blot assay were used to examine cell apoptosis and extracellular matrix (ECM) production. The interaction between miR-203 and LINC01116 or SMAD5 was predicted by bioinformatics analysis and verified by dual-luciferase reporter and RNA Immunoprecipitation (RIP) and RNA pull-down assays.

Results: LINC01116 and SMAD5 were upregulated while miR-203 was downregulated in keloid tissues and keloid fibroblasts. LINC01116 knockdown suppressed the proliferation, migration, invasion, and ECM production but induced apoptosis in keloid fibroblasts through enhancing miR-203 and inhibiting SMAD5. Moreover, SMAD5 was identified as a direct target of miR-203 and miR-203 could directly bind to LINC01116. Besides, LINC01116 regulated SMAD5 expression by targeting miR-203.

Conclusion: Downregulation of LINC01116 inhibited the progression of keloid formation by regulating miR-203/SMAD5 axis, which might provide a novel target for keloid therapy.

Keywords: Keloid formation; LINC01116; SMAD5; miR-203.

MeSH terms

  • China
  • Humans
  • Keloid / genetics
  • Keloid / metabolism*
  • Keloid / pathology
  • MicroRNAs / drug effects*
  • RNA, Long Noncoding / pharmacokinetics*
  • RNA, Long Noncoding / therapeutic use
  • Smad5 Protein / drug effects*

Substances

  • MIRN203 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding
  • SMAD5 protein, human
  • Smad5 Protein